Sharon Rosenzweig-Lipson
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.0MFederal grants as PI3 awards
0Patents grantedNone matched
92Papers4,805 citations
Federal awards and patents by year
AwardsPatents
3 awards · $2.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 13, 2021 | NIH | SBIR Phase II Structurally Diverse GABA-A a5 Positive Allosteric Modulators for Treatment of MCI due to AD | $626K | Agenebio, Inc. |
| Apr 19, 2021 | NIH | SBIR Phase II Structurally Diverse GABA-A a5 Positive Allosteric Modulators for Treatment of MCI due to AD | $235K | Agenebio, Inc. |
| Aug 7, 2019 | NIH | SBIR Phase II Structurally Diverse GABA-A ÃÂÃÂÃÂÃÂÃÂÃÂÃÂñ5 Positive Allosteric Modulators for Treatment of MCI due to AD | $1.1M | Agenebio, Inc. |
1 patents as inventor
- US Agenebio, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,062
Awards as PI#822
Patents#273
Companies
- Agenebio, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.